AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-12989454_ITM" title="Facts and information about Vivalis builds production facility.">Vivalis builds production facility.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
Vivalis builds production facility.
(From Chemical Business NewsBase - Die Pharmazeutische Industrie)
French biotechnology company Vivalis in Nantes plans to construct a production unit in Nantes for human vaccines and proteins for phase I and II of clinical trials. The vaccines will be developed against certain types of cancer and may also be used against the HIV virus and malaria. Vivalis will invest around EUR 3 M in the new site. The laboratory is scheduled to start operations in Jun …
Related articles from newspapers, magazines, journals, and more
